LHC.JSE Life Healthcare

Healthcare Health Care Providers & Services Johannesburg Exchange
1,271 ZAC
Close of Oct 29, 2026
1,007 1,283
Market cap
ZAC 18.1B
P/E
1,366.7x
P/B
162.99x
ROE
27.3%
Dividend yield
4.57%
Fundamental score
3.2/5

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is LHC.JSE undervalued?

Graham number

The Graham number of Life Healthcare cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Life Healthcare fundamental analysis

15 of 22 checks passed

ROE 2/2

High return on equity (27.3%), above 20%.

ROA 1/1

Return on assets (13.2%) is above the industry median (5.9%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-19.9%) is not above the 5-year average (152.3% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-19.9%) is below the industry median (-19.9%).

Revenue Growth 1/2

Revenue grew 6.9% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 1/2

Moderate debt to equity (42.6%), up to 100%.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 5.8x against interest expense, well covered.

PE vs Market 0/1

PE (13.6x) is above the market median (9.1x).

PE vs Industry 1/1

PE (13.6x) is below the industry median (22.9x).

PBV 0/1

Price to book (1.6x) is above the industry median (1.4x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 22.1, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.09, growth is cheap.

Dividend Yield 2/2

Dividend yield (9.9%) is in the top 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 0/1

Payout ratio is 135.4%, above 90% of earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Life Healthcare stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Life Healthcare

Life Healthcare Group Holdings Limited, an investment holding company, operates as a private healthcare company in Southern Africa. It operates through Southern Africa " Hospitals Services, Southern Africa - Complementary Services, Southern Africa - Healthcare Services, and International segments. The company operates acute hospitals; and Life Nkanyisa care centres that provide long-term chronic mental healthcare, frail care rehabilitation, step-down care, correctional servi…

Full company profile